Week in review: Atropine microdose, errant injection, ocular COVID

This week, Bausch acquires a microdose formulation of atropine, an injection of hyaluronic acid leads to severe complications and researchers report SARS-CoV-2 antigens can linger in ocular tissues mo

Read the full article here

Related Articles